chr12-6943843-C-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NR_023317.1(RNU7-1):n.28C>G variant causes a non coding transcript exon change. The variant allele was found at a frequency of 0.0000687 in 888,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000071 ( 0 hom. )
Consequence
RNU7-1
NR_023317.1 non_coding_transcript_exon
NR_023317.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.71
Genes affected
RNU7-1 (HGNC:34033): (RNA, U7 small nuclear 1) Implicated in Aicardi-Goutieres syndrome. [provided by Alliance of Genome Resources, Apr 2022]
C12orf57 (HGNC:29521): (chromosome 12 open reading frame 57) This gene is ubiquitously expressed in human tissues. It is required for development of the human corpus callosum. Mutations in this gene are associated with Temtamy syndrome (TEMTYS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-6943843-C-G is Pathogenic according to our data. Variant chr12-6943843-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1328141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNU7-1 | NR_023317.1 | n.28C>G | non_coding_transcript_exon_variant | 1/1 | |||
C12orf57 | NM_001301834.1 | c.-16+181C>G | intron_variant | ||||
C12orf57 | NM_001301836.2 | c.13+181C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNU7-1 | ENST00000458811.1 | n.28C>G | non_coding_transcript_exon_variant | 1/1 | |||||
ENST00000607421.2 | n.788G>C | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152210Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
9
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000706 AC: 52AN: 736144Hom.: 0 Cov.: 10 AF XY: 0.0000785 AC XY: 29AN XY: 369454
GnomAD4 exome
AF:
AC:
52
AN:
736144
Hom.:
Cov.:
10
AF XY:
AC XY:
29
AN XY:
369454
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74492
GnomAD4 genome
AF:
AC:
9
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | RNU7-1: PM3:Strong, PM2, PS1:Supporting - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 29, 2024 | Observed with a second RNU7-1 variant in a patient with nystagmus, microcephaly, and dystonia, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (PMID: 37171742); Published functional studies demonstrate severely impaired RNU7-1 function (PMID: 16547514); Also known as n.28C>G; This variant is associated with the following publications: (PMID: 16547514, 33230297, 37171742) - |
Aicardi-Goutieres syndrome 9 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jul 28, 2021 | The RNU7-1 n.28C>G variant is a non-protein coding variant that has not been reported in the peer-reviewed literature. However, a different nucleotide change at the same position, n.28C>T, has been reported in at least six individuals with Aicardi-Goutieres syndrome and elevated levels of interferon (Uggenti et al. 2020); in two of these individuals, the n.28C>T variant was confirmed in trans with the n.40_47del variant. The n.28C>G variant is reported at a frequency of 0.000196 in the Latino/Admixed American population of the Genome Aggregation Database (version 3.1.1), a frequency that is consistent with a rare autosomal recessive disorder. Nucleotide 28 is a key position of the sm-binding site, and functional studies have shown that the n.28C>G nucleotide substitution inhibits the assembly and processing efficiency of the U7 snRNP (Kolev and Steiz 2006). Based on the evidence, the n.28C>G variant is classified as likely pathogenic for Aicardi-Goutieres syndrome. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at